ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentAllschwilOncoGenomX AG
OncoGenomX AG Logo
Verified· 2 sources

OncoGenomX AG

Summary

About the company

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentMedical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Therapy decision support (Prediction Star)
Point-of-care technology platform to support therapy decisions in breast cancer; analyses tumour-specific genomic, biological, pathological and patient-specific clinical information and delivers analysis reports.
Analysis of tumour and patient data
Analysis of tumour-specific genomic, biological, pathological and patient-specific clinical information for classifying cancer and supporting evidence-based therapy decisions.
Intelligence-augmented Drug-Tumor-Matching
Intelligence-augmented assignment of drugs to tumours based on algorithm analyses and real-world outcome data to select suitable therapy combinations.
Treatment report and clinical decision support
Real-time delivery of analysis reports and easily understandable therapy recommendations to support the selection of evidence-based treatment regimens.
Comparisons

OncoGenomX AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank OncoGenomX AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of OncoGenomX AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Kreuzstrasse 4
4123 Allschwil

At a glance

Legal form
Corporation
UID
CHE-268.986.161
Founded
2019 · 7 years
Last commercial register change
October 22, 2024
Employees
1 to 10

Knowledge

No knowledge articles yet

Once OncoGenomX AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

CA
Crystallise! AG
Allschwil
AP
Actelion Pharmaceuticals Ltd
Allschwil
SB
Swiss Biome Institute GmbH
Allschwil
IA
InCephalo AG
Allschwil
VE
Vortex Europe AG
Allschwil
BP
Bright Peak Therapeutics AG
Allschwil
MA
Medcontrol AG
Liestal
VF
Verein für Krebsforschung
Arlesheim